ArticleBritish journal of cancer2017

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models.

Cristina Belgiovine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.